Recent Advances in the Diagnosis and Treatment of Liver Cirrhosis
Clicks: 1
ID: 309190
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #125 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The liver is an essential organ that carries out metabolism, detoxification, and processing of nutrients. Liver cirrhosis occurs when prolonged injury results in the replacement of normal liver tissue with scar tissue (fibrosis), which interferes with the function of the liver. The most frequent causes are chronic hepatitis C virus (HCV) infection and alcohol abuse. As cirrhosis advances, it becomes more challenging to diagnose and treat, hence posing a serious global health issue. Multiple etiologies are responsible for the causation of cirrhosis, such as alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and chronic viral hepatitis. The diagnosis is made with a combination of imaging studies and laboratory tests like magnetic resonance imaging (MRI) and ultrasound to determine liver damage. Cirrhosis was thought to be a irreversible condition previously, but current evidence indicates that advanced liver disease in some cases can be reversed. This has resulted in a change of nomenclature, with "advanced chronic liver disease" being used instead of "cirrhosis" to describe this changing concept. Treatment of chronic liver disease involves an extensive clinical evaluation, including symptoms, physical findings, medical history, and histological examination through biopsies or other investigations. Novel therapeutic strategies, such as gene therapy, stem cell therapy, and immunotherapy, are being investigated as novel avenues to enhance outcomes in patients. This research intends to integrate existing knowledge and new developments in hepatology, with observations that can guide future studies and improve clinical practice in the management of liver disease
| Reference Key |
imported_1761926622_6904ddde1fed2
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Swadesh Kumar Pattanik |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2025 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.